Transcriptomic profiling of microglia reveals signatures of cell activation and immune response, during experimental

Barbara Capuccini1, Jingwen Lin1, Carlos Talavera-López1

  • 1The Francis Crick Institute, London NW1 1AT, UK.

Scientific Reports
|December 20, 2016
PubMed

Insights

Microglia proliferate before experimental cerebral malaria (ECM) onset. During ECM, microglia activate immune responses, potentially driven by Type I Interferon, contributing to this severe brain inflammation.

Area of Science:

  • Neuroimmunology
  • Pathology
  • Molecular Biology

Background:

  • Cerebral malaria (CM) involves brain inflammation with activated immune cells.
  • Microglial responses in severe CM are poorly understood.
  • Experimental cerebral malaria (ECM) in mice provides a model to study CM.

Purpose of the Study:

  • To investigate microglial responses during experimental cerebral malaria (ECM).
  • To identify molecular mechanisms underlying microglial activation in ECM.

Main Methods:

  • Genome-wide transcriptomic analysis of microglia from infected mice.
  • Analysis of microglial proliferation and numbers in the brain.
  • In vitro cell culture to test Interferon-β effects on microglia.

Main Results:

  • Thousands of microglial transcripts were differentially expressed during ECM.
  • Microglial proliferation and increased cell numbers preceded ECM onset.
  • Immune response and chemokine genes upregulated during ECM, linked to Type I Interferon signaling.
  • A mutant parasite lacking ECM-inducing capacity showed reduced microglial activation.

Conclusions:

  • Microglia exhibit distinct activation and proliferation patterns during ECM.
  • Type I Interferon signaling plays a role in microglial immune responses in ECM.
  • These microglial responses are associated with the development of experimental cerebral malaria.

Related Concept Videos